Sign In
Buy BMRN
$56.47
+1.81 (+3.31%)
At Close: Jun 04, 2026
Biomarin Pharmaceutical's Earnings: A Preview
04:29pm, Monday, 03'rd Aug 2020
Biomarin Pharmaceutical (NASDAQ: BMRN) will be releasing its next round of earnings this Tuesday, August 04. For all of the relevant information, here is your guide for Tuesday's Q2 earnings announcem
Biomarin Pharmaceutical's Earnings: A Preview
12:29pm, Monday, 03'rd Aug 2020
Biomarin Pharmaceutical (NASDAQ: BMRN) will be releasing its next round of earnings this Tuesday, August 04.
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
CIBC Asset Management Inc Boosts Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
11:24am, Saturday, 01'st Aug 2020
CIBC Asset Management Inc raised its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) by 4.1% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 17,910 shar
Raymond James & Associates Decreases Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
10:48am, Saturday, 01'st Aug 2020
Raymond James & Associates lessened its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) by 1.4% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commis
The jobs report and congressional politics may matter more for markets than earnings in the week ahead
09:06pm, Friday, 31'st Jul 2020
The market could lose some exuberance as the calendar turns to August, and investors await Friday's July employment report.
BioMarin (BMRN) to Report Q2 Earnings: What's in the Cards?
01:55pm, Friday, 31'st Jul 2020
BioMarin (BMRN) is likely to provide an update on the sales of its key drugs Vimizim, Kuvan and others as well as how the pipeline has progressed when it reports Q2 earnings.
Investing Insights: 3 Stocks That Lost Their Spark and 3 Dividends That Caught Our Eye
12:00pm, Friday, 31'st Jul 2020
Our specialists also dive into what bonds are best for retirees and what role treasuries should play in a portfolio.
BioMarin (BMRN) to Report Q2 Earnings: What's in the Cards?
09:55am, Friday, 31'st Jul 2020
BioMarin (BMRN) is likely to provide an update on the sales of its key drugs Vimizim, Kuvan and others as well as how the pipeline has progressed when it reports Q2 earnings.
Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates
12:00am, Friday, 31'st Jul 2020
July turned out to be a mixed month for FDA approvals. Endo International PLC's (NASDAQ: ENDP) cellulite treatment, Osmotica Pharmaceuticals PLC's (NASDAQ: OSMT) eye...
10 Biggest Biotechnology Companies
11:32pm, Thursday, 30'th Jul 2020
With Novo Nordisk at the top of the list, these are the 10 biggest biotechnology companies by 12-month trailing revenue.
BioMarin Pharmaceutical (BMRN) Reports Next Week: Wall Street Expects Earnings Growth
04:33pm, Tuesday, 28'th Jul 2020
BioMarin (BMRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BioMarin Pharmaceutical (BMRN) Reports Next Week: Wall Street Expects Earnings Growth
12:33pm, Tuesday, 28'th Jul 2020
BioMarin (BMRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Biotech Bonanza - Second Half Outlook
08:24am, Tuesday, 28'th Jul 2020
Biotech is one of the rare industries whose prospects have improved as the year has progressed. A low interest rate environment, a less hostile regulatory environment, and strong investor interest cre
Pfizer Surges On Coronavirus Vaccine Supply Deals — But Is PFE Stock A Buy?
02:00pm, Monday, 27'th Jul 2020
Pfizer stock briefly broke out from a cup base as the Street intently watches its coronavirus vaccine efforts with BioNTech. But is the pharmaceutical company's stock a buy right now?
